Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127587822 | 12758782 | 2 | F | 20160627 | 20160920 | 20160919 | 20160929 | EXP | PHHY2016FR127096 | SANDOZ | 69.00 | YR | F | Y | 0.00000 | 20160929 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127587822 | 12758782 | 1 | SS | VANCOMYCIN SANDOZ | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 2 G, QD | 40 | G | Y | 0 | 2 | G | POWDER FOR SOL FOR INJ | QD | |||
| 127587822 | 12758782 | 2 | PS | RIMACTAN | RIFAMPIN | 1 | Oral | 300 MG, BID | 4800 | MG | Y | 64150 | 300 | MG | BID | ||||
| 127587822 | 12758782 | 3 | SS | AMBROXOL | AMBROXOL | 1 | Oral | 1 DF, TID | 12 | DF | Y | 0 | 1 | DF | SOLUTION | TID | |||
| 127587822 | 12758782 | 4 | SS | TAZOCILLINE | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Oral | 4 G, TID | 240 | G | Y | 0 | 4 | G | TID | ||||
| 127587822 | 12758782 | 5 | SS | DALACINE//CLINDAMYCIN HYDROCHLORIDE | CLINDAMYCIN HYDROCHLORIDE | 1 | Oral | 300 MG, 6QD | 14400 | MG | Y | 0 | 300 | MG | CAPSULE | ||||
| 127587822 | 12758782 | 6 | SS | CALCIPARINE | HEPARIN CALCIUM | 1 | Subcutaneous | 0.4 ML, QD | .667 | ML | Y | 0 | .4 | ML | SOLUTION FOR INJECTION | QD | |||
| 127587822 | 12758782 | 7 | SS | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | 75 MG, QD | 1950 | MG | Y | 0 | 75 | MG | POWDER FOR ORAL SOLUTION | QD | |||
| 127587822 | 12758782 | 8 | SS | LASILIX | FUROSEMIDE | 1 | Oral | 40 MG, QD | 1920 | MG | Y | 0 | 40 | MG | COATED TABLET | QD | |||
| 127587822 | 12758782 | 9 | SS | DIFFU K | POTASSIUM CHLORIDE | 1 | Oral | 600 MG, 6QD | 43200 | MG | Y | 0 | 600 | MG | |||||
| 127587822 | 12758782 | 10 | SS | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | Oral | 200 MG, UNK | Y | 0 | 200 | MG | COATED TABLET | ||||||
| 127587822 | 12758782 | 11 | SS | DOLIPRANE | ACETAMINOPHEN | 1 | Oral | 500 MG, BID | 8000 | MG | Y | 0 | 500 | MG | BID | ||||
| 127587822 | 12758782 | 12 | SS | FUMAFER | FERROUS FUMARATE | 1 | Oral | 66 MG, BID | 3432 | MG | Y | 0 | 66 | MG | COATED TABLET | BID | |||
| 127587822 | 12758782 | 13 | SS | GAVISCON | ALUMINUM HYDROXIDEMAGNESIUM CARBONATE | 1 | Oral | 1 DF, TID | 27 | DF | Y | 0 | 1 | DF | TID | ||||
| 127587822 | 12758782 | 14 | SS | LOVENOX | ENOXAPARIN SODIUM | 1 | Subcutaneous | 0.4 ML, QD | 19 | ML | Y | 0 | .4 | ML | QD | ||||
| 127587822 | 12758782 | 15 | SS | TIORFAN | RACECADOTRIL | 1 | Oral | 100 MG, TID | 900 | MG | Y | 0 | 100 | MG | CAPSULE | TID | |||
| 127587822 | 12758782 | 16 | SS | AMLOR | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, UNK | Y | 0 | 5 | MG | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127587822 | 12758782 | 1 | Sternitis |
| 127587822 | 12758782 | 2 | Sternitis |
| 127587822 | 12758782 | 3 | Bronchial disorder |
| 127587822 | 12758782 | 4 | Sternitis |
| 127587822 | 12758782 | 5 | Sternitis |
| 127587822 | 12758782 | 6 | Thrombosis prophylaxis |
| 127587822 | 12758782 | 7 | Product used for unknown indication |
| 127587822 | 12758782 | 8 | Cardiac failure |
| 127587822 | 12758782 | 9 | Hypokalaemia |
| 127587822 | 12758782 | 10 | Atrial fibrillation |
| 127587822 | 12758782 | 11 | Product used for unknown indication |
| 127587822 | 12758782 | 12 | Anaemia |
| 127587822 | 12758782 | 13 | Product used for unknown indication |
| 127587822 | 12758782 | 14 | Thrombosis prophylaxis |
| 127587822 | 12758782 | 15 | Diarrhoea |
| 127587822 | 12758782 | 16 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127587822 | 12758782 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127587822 | 12758782 | Acute kidney injury | |
| 127587822 | 12758782 | Drug reaction with eosinophilia and systemic symptoms | |
| 127587822 | 12758782 | Tubulointerstitial nephritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127587822 | 12758782 | 1 | 20160601 | 20160620 | 0 | |
| 127587822 | 12758782 | 2 | 20160620 | 20160628 | 0 | |
| 127587822 | 12758782 | 3 | 20160611 | 20160614 | 0 | |
| 127587822 | 12758782 | 4 | 20160601 | 20160620 | 0 | |
| 127587822 | 12758782 | 5 | 20160620 | 20160628 | 0 | |
| 127587822 | 12758782 | 6 | 20160626 | 20160628 | 0 | |
| 127587822 | 12758782 | 7 | 20160602 | 20160809 | 0 | |
| 127587822 | 12758782 | 8 | 20160510 | 20160626 | 0 | |
| 127587822 | 12758782 | 9 | 20160611 | 20160622 | 0 | |
| 127587822 | 12758782 | 10 | 20160602 | 20160701 | 0 | |
| 127587822 | 12758782 | 11 | 20160615 | 20160622 | 0 | |
| 127587822 | 12758782 | 12 | 20160602 | 20160708 | 0 | |
| 127587822 | 12758782 | 13 | 20160615 | 20160623 | 0 | |
| 127587822 | 12758782 | 14 | 20160509 | 20160625 | 0 | |
| 127587822 | 12758782 | 15 | 20160625 | 20160708 | 0 | |
| 127587822 | 12758782 | 16 | 20160625 | 20160708 | 0 |